Santhera Pharmaceuticals
Clinical trials sponsored by Santhera Pharmaceuticals, explained in plain language.
-
Promising new drug may offer safer option for duchenne boys
Disease control CompletedThis study tested a drug called vamorolone in 54 boys with Duchenne muscular dystrophy (DMD), a muscle-weakening disease. The goal was to see if it is safe and can help control the disease with fewer side effects than standard steroids. Boys aged 2 to under 4 and 7 to under 18 to…
Phase: PHASE2 • Sponsor: Santhera Pharmaceuticals • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
Healthy volunteers help test vamorolone's hidden salt switch
Knowledge-focused CompletedThis completed Phase 1 study in 30 healthy adults tested whether the drug vamorolone can block the mineralocorticoid receptor, which helps control salt and water balance. Participants received vamorolone, a comparison drug, or no treatment, and researchers measured urine sodium a…
Phase: PHASE1 • Sponsor: Santhera Pharmaceuticals • Aim: Knowledge-focused
Last updated May 26, 2026 07:50 UTC
-
Healthy volunteers help uncover Vamorolone's drug interaction risks
Knowledge-focused CompletedThis study looked at how vamorolone, a potential treatment for certain muscle diseases, affects the way the body processes another drug called midazolam. 18 healthy adults took midazolam before and after vamorolone to see if vamorolone changes how midazolam is broken down. The re…
Phase: PHASE1 • Sponsor: Santhera Pharmaceuticals • Aim: Knowledge-focused
Last updated May 26, 2026 07:27 UTC